Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022–May 2023
Open Access
- 14 November 2023
- Vol. 42 (10) , 2543-2552
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Preventing SARS-CoV-2 Transmission in Health Care Settings in the Context of the Omicron VariantJAMA, 2022
- Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care PersonnelNew England Journal of Medicine, 2021
- Immune imprinting and SARS-CoV-2 vaccine designTrends in Immunology, 2021
- Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 VaccinesEpidemiology, 2021
- Prospects for durable immune control of SARS-CoV-2 and prevention of reinfectionNature Reviews Immunology, 2021
- Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2JAMA, 2021
- A Test-Negative Design with Additional Population Controls Can Be Used to Rapidly Study Causes of the SARS-CoV-2 EpidemicEpidemiology, 2020
- Test-Negative DesignsEpidemiology, 2019
- Confounding, effect modification, and the odds ratio: common misinterpretationsJournal of Clinical Epidemiology, 2015
- Logistic Regression in Practice2014